1. Sézary syndrome managed with histone deacetylase inhibitor followed by anti‐CCR4 monoclonal antibody. (12th January 2018) Authors: Numata, T.; Nagatani, T.; Shirai, K.; Maeda, T.; Mae, K.; Nakasu, M.; Saito, M.; Usuda, T.; Tsuboi, R.; Okubo, Y. Journal: Clinical and experimental dermatology Issue: Volume 43:Number 3(2018) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sézary syndrome managed with histone deacetylase inhibitor followed by anti‐CCR4 monoclonal antibody. (1st April 2018) Authors: Numata, T.; Nagatani, T.; Shirai, K.; Maeda, T.; Mae, K.; Nakasu, M.; Saito, M.; Usuda, T.; Tsuboi, R.; Okubo, Y. Journal: Clinical and experimental dermatology Issue: Volume 43:Number 3(2018) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗